![](/img/cover-not-exists.png)
EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies
O'Mahony, D., Morris, J. C., Stetler-Stevenson, M., Matthews, H., Brown, M. R., Fleisher, T., Pittaluga, S., Raffeld, M., Albert, P. S., Reitsma, D., Kaucic, K., Hammershaimb, L., Waldmann, T. A., JanVolume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-08-1254
Date:
March, 2009
File:
PDF, 660 KB
english, 2009